Skip to main navigation Skip to search Skip to main content

WS13.2 The role of PGE 2 in cystic fibrosis (CF) lung inflammation and the potential association with ivacaftor therapy and treatment response

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Cystic Fibrosis
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Ivacaftor
  • Cystic fibrosis
  • Medicine
  • Inflammation
  • Lung
  • Internal medicine
  • Gastroenterology
  • Cystic fibrosis transmembrane conductance regulator

Cite this